11 BIT STUDIOS SA ZY -,10/ PL11BTS00015 /
2024-04-24 4:13:33 PM | Chg. +2.600 | Volume | Bid4:23:04 PM | Ask4:23:04 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
119.600EUR | +2.22% | 12 Turnover: 1,382.400 |
119.000Bid Size: 25 | 123.200Ask Size: 25 | 286.02 mill.EUR | - | - |
GlobeNewswire
4:20 PM
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Evolv Technologies Holdings, ...
GlobeNewswire
4:09 PM
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antib...
GlobeNewswire
4:08 PM
Blue Island Homes Chosen as Exclusive Listing Brokers for Ocean Watch at Harbor Pointe: A Premier Ga...
GlobeNewswire
4:06 PM
Juniata Valley Financial Corp. Announces Results for the Quarter Ended March 31, 2024
GlobeNewswire
4:05 PM
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad R...
GlobeNewswire
4:05 PM
Volvo Trucks North America Continues ‘Toward Zero’ by Fueling All New Trucks with HVO at the New Riv...
GlobeNewswire
4:05 PM
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ...
GlobeNewswire
4:05 PM
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 Amer...
GlobeNewswire
4:02 PM
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
GlobeNewswire
4:01 PM
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
4:00 PM
ML Tech’s Digital Asset Market Neutral Opportunities Fund Reaches Milestone of Six Months of Live Tr...
GlobeNewswire
4:00 PM
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASC...
GlobeNewswire
4:00 PM
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of ob...
GlobeNewswire
4:00 PM
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual...
GlobeNewswire
4:00 PM
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B...
GlobeNewswire
4:00 PM
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting